HIV Citations List: September 2024
Literature Citations
1. Quinazolinone-based Subchemotypes for Targeting HIV-1 Capsid Protein: Design and Synthesis. Akther, T., W.M. McFadden, H.C. Zhang, K.A. Kirby, S.G. Sarafianos, and Z.Q. Wang. Medicinal Chemistry Research, 2024. ISI[001312096400001].
[WOS]. HIV_09_2024.
2. A Comparison of Sanger Sequencing and Amplicon-Based Next Generation Sequencing Approaches for the Detection of HIV-1 Drug Resistance Mutations. Biba, C., L. Fiaschi, I. Varasi, C. Paletti, N. Bartolini, M. Zazzi, I. Vicenti, and F. Saladini. Viruses, 2024. 16(9). PMID[39339940]. PMCID[PMC11437444].
[PubMed]. HIV_09_2024.
3. Long-term Antiretroviral Therapy Rejuvenates the HIV-Specific CD8(+) T Cell Response. Blankson, J.N. Nature Immunology, 2024. 25(9): p. 1513-1514. PMID[39179933].
[PubMed]. HIV_09_2024.
4. Acetylation of SAMHD1 at Lysine 580 Is Crucial for Blocking HIV-1 Infection. Bulnes-Ramos, A., K. Schott, J. Rabinowitz, C. Luchsinger, C. Bertelli, E. Miyagi, C.H. Yu, M. Persaud, C. Shepard, R. König, B. Kim, D.N. Ivanov, K. Strebel, and F. Diaz-Griffero. mBio, 2024. 15(9): p. e0195824. PMID[39162568]. PMCID[PMC11389391].
[PubMed]. HIV_09_2024.
5. Release of P-TEFb from the Super Elongation Complex Promotes HIV-1 Latency Reversal. Cisneros, W.J., S.H.A. Soliman, M. Walter, L.M. Simons, D. Cornish, S. De Fabritiis, A.W. Halle, E.Y. Kim, S.M. Wolinsky, R. Lorenzo-Redondo, A. Shilatifard, and J.F. Hultquist. PLOS Pathogens, 2024. 20(9): p. e1012083. PMID[39259751]. PMCID[PMC11419360].
[PubMed]. HIV_09_2024.
6. Sulfoglycodendron Antivirals with Scalable Architectures and Activities. Coppola, F., R. Jafari, K.D. McReynolds, and P. Král. Journal of Chemical and Informational Modeling, 2024. 64(18): p. 7141-7151. PMID[39230262].
[PubMed]. HIV_09_2024.
7. HIV-1 Controllers Exhibit an Enhanced Antiretroviral Innate State Characterised by Overexpression of p21 and MCPIP1 and Silencing of ERVK-6 RNA Expression. de Azevedo, S.S.D., M. Ribeiro-Alves, F.H. Côrtes, E. Delatorre, B. Hoagland, L.M. Villela, B. Grinsztejn, V.G. Veloso, M.G. Morgado, T.M.L. Souza, and G. Bello. Memórias do Instituto Oswaldo Cruz, 2024. 119: p. e240071. PMID[39292108]. PMCID[PMC11404982].
[PubMed]. HIV_09_2024.
8. Allosteric Modulation of the CXCR4:CXCL12 Axis by Targeting Receptor Nanoclustering Via the TMV-TMVI Domain. García-Cuesta, E.M., P. Martínez, K. Selvaraju, G. Ulltjärn, A.M. Gómez Pozo, G. D'Agostino, S. Gardeta, A. Quijada-Freire, P. Blanco Gabella, C. Roca, D.D. Hoyo, R. Jiménez-Saiz, A. García-Rubia, B. Soler Palacios, P. Lucas, R. Ayala-Bueno, N. Santander Acerete, Y. Carrasco, C. Oscar Sorzano, A. Martinez, N.E. Campillo, L.D. Jensen, J.M. Rodriguez Frade, C. Santiago, and M. Mellado. eLife, 2024. 13. PMID[39248648]. PMCID[PMC11383527].
[PubMed]. HIV_09_2024.
9. Design of Substituted Tetrahydrofuran Derivatives for HIV-1 Protease Inhibitors: Synthesis, Biological Evaluation, and X-Ray Structural Studies. Ghosh, A.K., D. Lee, A. Sharma, M.E. Johnson, A.K. Ghosh, Y.F. Wang, J. Agniswamy, M. Amano, S.I. Hattori, I.T. Weber, and H. Mitsuya. Organic & Biomolecular Chemistry, 2024. 22(36): p. 7354-7372. PMID[38973505].
[PubMed]. HIV_09_2024.
10. The HIV-1 Capsid Serves as a Nanoscale Reaction Vessel for Reverse Transcription. Jennings, J., H. Bracey, J. Hong, D.T. Nguyen, R. Dasgupta, A.V. Rivera, N. Sluis-Cremer, J. Shi, and C. Aiken. PLOS Pathogens, 2024. 20(9): p. e1011810. PMID[39226318]. PMCID[PMC11398657].
[PubMed]. HIV_09_2024.
11. Evaluating the Use of Sacran, a Polysaccharide Isolated from Aphanothece sacrum, as a Possible Microbicide for Preventing HIV-1 Infection. Matsuda, K., R. Kariya, K. Maeda, and S. Okada. Viruses, 2024. 16(9). PMID[39339979]. PMCID[PMC11437396].
[PubMed]. HIV_09_2024.
12. K103N, V106M and Y188L Significantly Reduce HIV-1 Subtype C Phenotypic Susceptibility to Doravirine. Reddy, N., M. Papathanasopoulos, K. Steegen, and A.E. Basson. Viruses, 2024. 16(9). PMID[39339969]. PMCID[PMC11437401].
[PubMed]. HIV_09_2024.
13. Putting a Kink in HIV-1 Particle Infectivity: Rocaglamide Inhibits HIV-1 Replication by Altering Gag-genomic RNA Interaction. Rosenfeld, P., G. Singh, A. Paz Herrera, J. Ji, B. Seufzer, X. Heng, K. Boris-Lawrie, and A. Cochrane. Viruses, 2024. 16(9). PMID[39339982]. PMCID[PMC11437399].
[PubMed]. HIV_09_2024.
14. Investigation of the Permeability of Antiretroviral Drugs Lamivudine and Valganciclovir via Single-pass Intestinal Perfusion (SPIP) Method. Sanli, S., M.S. Kaynak, N. Sanli, and E.E. Balta. Current Pharmaceutical Analysis, 2024. ISI[001299808000001].
[WOS]. HIV_09_2024.
15. Transcription of HIV-1 at Sites of Intact Latent Provirus Integration. Teixeira, A.R., C. Bittar, G.S. Silva Santos, T.Y. Oliveira, A.S. Huang, N. Linden, I. Ferreira, T. Murdza, F. Muecksch, R.B. Jones, M. Caskey, M. Jankovic, and M.C. Nussenzweig. Journal of Experimental Medicine, 2024. 221(9). PMID[39141127]. PMCID[PMC11323366].
[PubMed]. HIV_09_2024.
Patent Citations
This month, no relevant HIV patents were identified.